These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
163 related articles for article (PubMed ID: 38579044)
1. Network pharmacology and molecular docking analysis on the mechanism of Tripterygium wilfordii Hook in the treatment of Sjögren syndrome. Wang Z; Xu Y; Liang S Medicine (Baltimore); 2024 Apr; 103(14):e37532. PubMed ID: 38579044 [TBL] [Abstract][Full Text] [Related]
2. Multi-target mechanism of Zhang J; Zhou Y; Ma Z Ann Med; 2021 Dec; 53(1):1090-1098. PubMed ID: 34259096 [TBL] [Abstract][Full Text] [Related]
3. Exploring the pharmacological mechanism of Tripterygium wilfordii hook for treatment of Behcet's disease using network pharmacology and molecular docking. Ye L; Li C; Zhao X; Ou W; Wang L; Wan M Medicine (Baltimore); 2023 Oct; 102(42):e34512. PubMed ID: 37861497 [TBL] [Abstract][Full Text] [Related]
4. A network pharmacology study on the Tripteryguim wilfordii Hook for treatment of Crohn's disease. Zhang J; Huang Q; Zhao R; Ma Z BMC Complement Med Ther; 2020 Mar; 20(1):95. PubMed ID: 32293395 [TBL] [Abstract][Full Text] [Related]
5. Uncovering the molecular mechanism of Mume Fructus in treatment of Sjögren's syndrome. Sun Z; Deng L; Xu Z; Yang K; Yu P Medicine (Baltimore); 2024 May; 103(19):e38085. PubMed ID: 38728503 [TBL] [Abstract][Full Text] [Related]
6. Mechanism of Lu L; Peng J; Wan P; Peng H; Lu J; Xiong G Front Pharmacol; 2022; 13():940773. PubMed ID: 36386135 [No Abstract] [Full Text] [Related]
7. Network pharmacology identifies the inhibitory effect of Yiqiyangyinquyu prescription on salivary gland inflammation in Sjögren's syndrome. Hong T; Chen W; Ren YT; Wang YH; Lu DQ; Zhang KY; Yao XY; Wang XC Medicine (Baltimore); 2023 Nov; 102(47):e36144. PubMed ID: 38013284 [TBL] [Abstract][Full Text] [Related]
8. Identification of Fangji Huangqi Tang as a potential herbal formula for Sjogren syndrome treatment via network pharmacology and experimental validation. Shao Y; Hu J; Wang S; Jiang H; Miao G; Li C; Zhang J; Xu Y Chem Biol Drug Des; 2023 Dec; 102(6):1435-1447. PubMed ID: 37640538 [TBL] [Abstract][Full Text] [Related]
9. Mechanism of action of Shi H; Hou Y; Su X; Qiao J; Wang Q; Guo X; Gao Z; Wang L Ren Fail; 2022 Dec; 44(1):116-125. PubMed ID: 35172688 [TBL] [Abstract][Full Text] [Related]
10. Potential Molecular Mechanisms of Ephedra Herb in the Treatment of Nephrotic Syndrome Based on Network Pharmacology and Molecular Docking. Yao T; Wang Q; Han S; Lu Y; Xu Y; Wang Y Biomed Res Int; 2022; 2022():9214589. PubMed ID: 35837376 [TBL] [Abstract][Full Text] [Related]
11. Research on the Mechanism of Guizhi to Treat Nephrotic Syndrome Based on Network Pharmacology and Molecular Docking Technology. He D; Li Q; Du G; Sun J; Meng G; Chen S Biomed Res Int; 2021; 2021():8141075. PubMed ID: 34873575 [TBL] [Abstract][Full Text] [Related]
12. Network pharmacology and molecular docking analysis on the mechanism of Baihe Zhimu decoction in the treatment of postpartum depression. Zhao Q; Pan W; Shi H; Qi F; Liu Y; Yang T; Si H; Si G Medicine (Baltimore); 2022 Oct; 101(43):e29323. PubMed ID: 36316904 [TBL] [Abstract][Full Text] [Related]
13. Identification of bioactive compounds and potential mechanisms of scutellariae radix-coptidis rhizoma in the treatment of atherosclerosis by integrating network pharmacology and experimental validation. Ji L; Song T; Ge C; Wu Q; Ma L; Chen X; Chen T; Chen Q; Chen Z; Chen W Biomed Pharmacother; 2023 Sep; 165():115210. PubMed ID: 37499457 [TBL] [Abstract][Full Text] [Related]
14. [Mechanism of Zixin Biqiu Granules in treatment of allergic rhinitis based on network pharmacology and molecular docking technology]. Yuan AL; Ming Y; Zhang XY; Shu XY Zhongguo Zhong Yao Za Zhi; 2022 Oct; 47(19):5344-5352. PubMed ID: 36472042 [TBL] [Abstract][Full Text] [Related]
15. Exploring the mechanism of Erchen decoction in the treatment of atherosclerosis based on network pharmacology and molecular docking. Li W; Zhang G; Zhao Z; Zuo Y; Sun Z; Chen S Medicine (Baltimore); 2023 Nov; 102(46):e35248. PubMed ID: 37986321 [TBL] [Abstract][Full Text] [Related]
16. Exploring the Pharmacological Mechanisms of Huang B; Huang C; Zhu L; Xie L; Wang Y; Zhu N Biomed Res Int; 2021; 2021():5575621. PubMed ID: 34435046 [TBL] [Abstract][Full Text] [Related]
17. Exploring the mechanism of Ginkgo biloba L. leaves in the treatment of vascular dementia based on network pharmacology, molecular docking, and molecular dynamics simulation. Pan J; Tang J; Gai J; Jin Y; Tang B; Fan X Medicine (Baltimore); 2023 May; 102(21):e33877. PubMed ID: 37233418 [TBL] [Abstract][Full Text] [Related]
18. A Network Pharmacology-Based Strategy for Unveiling the Mechanisms of Tripterygium Wilfordii Hook F against Diabetic Kidney Disease. Wang Y; Liu T; Ma F; Lu X; Mao H; Zhou W; Yang L; Li P; Zhan Y J Diabetes Res; 2020; 2020():2421631. PubMed ID: 33274236 [TBL] [Abstract][Full Text] [Related]
19. Integrating network pharmacology and experimental verification to explore the mechanism of Tripterygium wilfordii in ankylosing spondylitis. Chen Y; Liu Z; Yu Q; Qu X; Liu H Medicine (Baltimore); 2023 Dec; 102(50):e36580. PubMed ID: 38115356 [TBL] [Abstract][Full Text] [Related]
20. Potential shared therapeutic and hepatotoxic mechanisms of Tripterygium wilfordii polyglycosides treating three kinds of autoimmune skin diseases by regulating IL-17 signaling pathway and Th17 cell differentiation. Chen Y; Wang YF; Song SS; Zhu J; Wu LL; Li XY J Ethnopharmacol; 2022 Oct; 296():115496. PubMed ID: 35750104 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]